Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Jochen Müller-Ehmsen"'
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background This study aimed to evaluate cost-utility of baroreflex activation therapy (BAT) using the Barostim neo™ device (CVRx Inc., Minneapolis, MN, USA) compared with optimized medical management in patients with advanced chronic heart
Externí odkaz:
https://doaj.org/article/5bff1cba27f54f95b06a5b11aa6fecfd
Autor:
Tobias Hannes, Marie Wolff, Michael Xavier Doss, Kurt Pfannkuche, Moritz Haustein, Jochen Müller-Ehmsen, Agapios Sachinidis, Jürgen Hescheler, Markus Khalil, Marcel Halbach
Publikováno v:
Cellular Physiology and Biochemistry, Vol 35, Iss 1, Pp 305-314 (2015)
Background: Modelling of cardiac development, physiology and pharmacology by differentiation of embryonic stem cells (ESCs) requires comparability of cardiac differentiation between different ESC lines. To investigate whether the outcome of cardiac d
Externí odkaz:
https://doaj.org/article/07494d3765b04c6db4e3f810f3ca851b
Autor:
Martina Maass, Benjamin Krausgrill, Simon Eschrig, Tobias Kaluschke, Katja Urban, Gabriel Peinkofer, Tobias G. Plenge, Simon Oeckenpöhler, Martin Raths, Dennis Ladage, Marcel Halbach, Jürgen Hescheler, Jochen Müller-Ehmsen
Publikováno v:
Cell Transplantation, Vol 26 (2017)
Cardiac cell replacement therapy is a promising therapy to improve cardiac function in heart failure. Persistence, structural and functional maturation, and integration of transplanted cardiomyocytes into recipients' hearts are crucial for a safe and
Externí odkaz:
https://doaj.org/article/be7aa6e958f44ee1bd40aecbdba07f0b
Autor:
Michael Huntgeburth, Klaus Tiemann, Robert Shahverdyan, Klaus-Dieter Schlüter, Rolf Schreckenberg, Marie-Luise Gross, Sonja Mödersheim, Evren Caglayan, Jochen Müller-Ehmsen, Alexander Ghanem, Marius Vantler, Wolfram H Zimmermann, Michael Böhm, Stephan Rosenkranz
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e26628 (2011)
BACKGROUND: Neuroendocrine activation and local mediators such as transforming growth factor-β₁ (TGF-β₁) contribute to the pathobiology of cardiac hypertrophy and failure, but the underlying mechanisms are incompletely understood. We aimed to c
Externí odkaz:
https://doaj.org/article/db5495e56a5047c69fd098a876e144cd
Autor:
Alexander Ghanem, Agnieszka Ziomka, Benjamin Krausgrill, Kerstin Schenk, Clemens Troatz, Tomas Miszalski-Jamka, Georg Nickenig, Klaus Tiemann, Jochen Müller-Ehmsen
Publikováno v:
Cell Transplantation, Vol 18 (2009)
Intramyocardial transplantation of bone marrow-derived stem cells is a potential therapeutic option after myocardial infarction (MI). Intramyocardial administration is invasive but allows efficient and targeted stem cell delivery. Aims of this study
Externí odkaz:
https://doaj.org/article/30cfa2e93d6d45d29888ee24a5c4883d
Autor:
Benjamin Krausgrill, Marius Vantler, Volker Burst, Martin Raths, Marcel Halbach, Konrad Frank, Silke Schynkowski, Kerstin Schenk, Jürgen Hescheler, Stephan Rosenkranz, Jochen Müller-Ehmsen PD Dr. med.
Publikováno v:
Cell Transplantation, Vol 18 (2009)
Bone marrow cells are used for cell therapy after myocardial infarction (MI) with promising results. However, cardiac persistence of transplanted cells is rather low. Here, we investigated strategies to increase the survival and cardiac persistence o
Externí odkaz:
https://doaj.org/article/c1a4649037144029b433f980f8fd752f
Publikováno v:
Fortschritte der Neurologie, Psychiatrie 90(12), a-1802-3852 (2022). doi:10.1055/a-1802-3852
ZusammenfassungEine akute Aortendissektion ist selten, aber lebensbedrohlich. Die Symptome hängen von der Lokalisation und Minderperfusion der nachgeschalteten Organe oder Extremitäten ab und sind dementsprechend variabel. Es können neurologische
Autor:
Carsten Tschöpe, Klaus Empen, Heiko Mahrholdt, Eed Abu-Zaid, Meinrad Gawaz, Jochen Müller-Ehmsen, Andreas Seitz, Gerd Peter Meyer, Kai C. Wollert, Arnold Ganser, Andreas E. May, Stephan B. Felix, Jens Pirr, Emmanuel Chorianopoulos, Benedikta Ritter, Dennis Ladage, Lubomir Arseniev, Johann Bauersachs, Hugo A. Katus, Heinz-Peter Schultheiss, Simon Greulich, Hans-Gert Heuft
Publikováno v:
Clinical Research in Cardiology. 109:539-548
In the placebo-controlled, double-blind BOne marrOw transfer to enhance ST-elevation infarct regeneration (BOOST) 2 trial, intracoronary autologous bone marrow cell (BMC) transfer did not improve recovery of left ventricular ejection fraction (LVEF)
Autor:
Johannes Waltenberger, Stephan B. Felix, Dennis Ladage, Dieter Fischer, Lubomir Arseniev, Jan E. Brinchmann, Gerd Peter Meyer, Klaus Empen, Andreas E. May, Jochen Müller-Ehmsen, Kai C. Wollert, Arnold Ganser, Heiko Mahrholdt, Ulrich Tebbe, Diethelm Messinger, Hugo A. Katus, Bernd Hertenstein, Heinz-Peter Schultheiss, Johann Bauersachs, Alf Inge Larsen, Vernon V.S. Bonarjee, Jens Pirr, Mortimer Korf-Klingebiel, Carsten Tschöpe, Meinrad Gawaz, Kenneth Dickstein, Hans-Gert Heuft, Simon Greulich, Emmanuel Chorianopoulos, Benedikta Ritter
Publikováno v:
European Heart Journal. 38:2936-2943
Aims Intracoronary infusion of autologous nucleated bone marrow cells (BMCs) enhanced the recovery of left ventricular ejection fraction (LVEF) after ST-segment elevation myocardial infarction (STEMI) in the randomised-controlled, open-label BOOST tr
Autor:
Parwis B. Rahmanian, Elisa Klask, Martin Hellmich, Andre Reklat, Jochen Müller-Ehmsen, Frank Vitinius, Christian Albus, Roman Pfister, Thorsten Wahlers
Publikováno v:
Clinical Transplantation. 33
Background Only a few previous studies have focused on the interaction between pretransplant psychological variables, survival on the waiting list, and adherence to therapy after heart transplantation (HTx). Methods This work combined two studies: St